Voretigene Neparvovec

voretigene neparvovec · Spark Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Voretigene Neparvovec, covering 2025-04-25 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy [Phase 3]

See pricing